JP Morgan Growth Equity Partners

VC New York, United States · Founded 2018

J.P. Morgan Growth Equity Partners invests in growth-stage and late-stage technology, consumer, and tech-enabled healthcare companies. The fund leverages the broader J.P. Morgan ecosystem, global network, and extensive data resources to accelerate scaling and deliver strategic value post-investment.

About JP Morgan Growth Equity Partners

JP Morgan Growth Equity Partners is the growth equity arm of JPMorgan Chase, deploying balance sheet and managed capital into late-stage technology and healthcare companies, with a focus on growth and pre-IPO rounds. The platform writes large checks, typically $25M to $150M, into companies with established commercial traction, strong financial metrics, and clear paths to public markets or strategic exits. Healthcare exposure is meaningful and concentrated in healthcare technology, services, and selectively life sciences with commercial revenue, leveraging JP Morgan’s healthcare investment banking practice for deal sourcing. AI focus is welcome where it sits inside a defensible healthcare or technology business with clear unit economics. Founders best suited are growth and late-stage CEOs with $30M-plus revenue, audited financials, and clear paths to either IPO or strategic acquisition, who would benefit from a deep-pocketed, late-stage lead with bank-affiliated relationships across capital markets and M and A. Founders who do not fit include seed, Series A, and Series B teams, pre-revenue biotech, and consumer wellness without enterprise buyers. Geographic preference is global with a US focus. The entry path is warm introduction through a JP Morgan healthcare investment banker, a healthcare crossover investor, or a portfolio CEO. LinkedIn outreach is unlikely to convert without a clear late-stage fit and strong reference path. Expect a deliberate, evidence-driven diligence process and a partner that values pricing discipline and downside protection alongside upside scenarios.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by JP Morgan Growth Equity Partners

Tools made by companies in JP Morgan Growth Equity Partners's portfolio that we cover in the directory.

Nourish (for providers)
Nourish
Endocrinology & Metabolic AI
Nourish offers an AI-powered platform connecting patients with Registered Dietitians for virtual nutrition counseling, with 94% of patients paying $0 out-of-pocket due to insurance partnerships. The platform includes AI-powered meal logging for patients and AI-driven insights for providers, aiming to make nutrition care more accessible, effective, and human.

Portfolio companies in our directory

Other portfolio companies

Companies in JP Morgan Growth Equity Partners's portfolio not currently in our directory.

Team

Christopher Dawe
Managing Partner and Head of Growth Equity Partners
Paris Heymann
Co-Managing Partner
Patrick McGoldrick
Partner
Luke Sikora
Managing Director and Partner

Pitch / review this investor

Have you raised from JP Morgan Growth Equity Partners? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.